Pain News and Research

Latest Pain News and Research

Gluten-free diet may help protect against neuropathic pain

A strict gluten-free diet may help protect against the nerve pain that some people with gluten sensitivity experience, according to a preliminary study released today that will be presented at the American Academy of Neurology's 70th Annual Meeting in Los Angeles, April 21 to 27, 2018.

1 Mar 2018

Hip replacement surgery associated with increased life expectancy, study reports

Hip replacement surgery not only improves quality of life but is also associated with increased life expectancy, compared to people of similar age and sex, reports a study in Clinical Orthopaedics and Related Research, a publication of The Association of Bone and Joint Surgeons.

28 Feb 2018

Search engine queries reflect geographic distribution of coronary heart disease

Search engine queries related to common heart disease symptoms track closely with geographic and seasonal trends for coronary heart disease hospitalizations, according to research being presented at the American College of Cardiology's 67th Annual Scientific Session.

28 Feb 2018

Never too late to operate? Surgery near end of life is common, costly

At 87, Maxine Stanich cared more about improving the quality of her life than prolonging it. She suffered from a long list of health problems, including heart failure and chronic lung disease that could leave her gasping for breath.

28 Feb 2018

Football linked to changes in cardiac structure and greater risk of heart rhythm disorders

Football players show structural changes in the heart and face an elevated risk of heart rhythm disorders later in life, according to research presented at the American College of Cardiology's 67th Annual Scientific Session.

28 Feb 2018

Failed osteoarthritis drug may help lessen opioid dependence

A new study from Indiana University suggests that a drug proven safe for use in people may prevent opioid tolerance and physical dependence when used in combination with opioid-based pain medications.

27 Feb 2018

Standing desks may not be as good for health as previously thought

Trending at offices are standing desks that allows the user to stand for longer hours in an attempt to reduce sedentary time. While sitting for a long period of time is not a good idea, a new study finds that standing for long hours may not be good for health either.

27 Feb 2018

Expanded model of care could relieve depression and fatigue in chronic heart failure patients

Patients with chronic heart failure face related problems, such as depression and fatigue, that could be relieved by an expanded model of care, according to a recently published study led by a researcher from the University of Colorado School of Medicine.

27 Feb 2018

ANU research explores way to reduce unwanted side-effects of common drugs

New research from The Australian National University has drilled down to the molecular level to find similarities across six pharmaceutical drugs used in pain relief, dentist anesthetic, and treatment of epilepsy, in a bid to find a way to reduce unwanted side-effects.

27 Feb 2018

University of Illinois at Chicago awarded $4.6 million NIH grant for chronic pain research

The University of Illinois at Chicago has been awarded a $4.6 million grant from the National Heart, Lung, and Blood Institute to study the molecular neurobiology of chronic pain in patients with sickle cell disease and to develop potential new drug treatments.

26 Feb 2018

Actual experiences with modern breast radiation therapy found to be better than expected

A new study reveals that many patients with breast cancer have misconceptions and fears about radiation therapy, but their actual experiences with modern breast radiation therapy are better than they expected.

26 Feb 2018

Research reveals anti-cancer effects of natural extract from Daffodils

A research describes the anti-cancer effects of a natural alkaloid extracted from Daffodils. Led by Denis Lafontaine, affiliated with the Faculty of Sciences at the ULB, the researchers have discovered that this compound triggers the activation of an anti-tumoral surveillance pathway.

26 Feb 2018

Onsite imaging services play important role in managing sports-related injuries

The Olympic Games give elite athletes a chance at athletic triumph, but also carry a risk of injury. When injuries occur, it is critical that they be evaluated quickly.

26 Feb 2018

Many people not sure how to respond during heart health emergency, survey finds

Would you know what to do if a man or woman at your son's baseball game went into cardiac arrest? Would you recognize the signs if you were having a heart attack? A new survey by Valley's cardiovascular affiliate Cleveland Clinic reveals that many Americans aren't sure.

24 Feb 2018

Steps to take for boosting immune system and maintaining a healthy body

We know that germs can make you sick, but if you seem to constantly be under the weather with cold symptoms, could it be something other than germs that are getting you down?

24 Feb 2018

Repeated sick days do not affect children's learning ability, study shows

A fevered and listless child with ear pain, a bad cough or snot running out of their nose is a well-known phenomenon in most families with children.

23 Feb 2018

Catheter-based procedure increases treatment options for mitral valve disease

Some heart patients haven't yet been able to access the growing trend toward minimally invasive procedures. A new clinical trial, though, makes a form of mitral valve repair an option without an open-heart surgery.

22 Feb 2018

UNIST researchers introduce new biosensing contact lens for diabetics

A team of researchers, affiliated with UNIST has recently introduced a new biosensing contact lens capable of detecting glucose levels in patients with diabetes.

22 Feb 2018

Younger women with SCAD may benefit most from conservative treatment

Patients who suffer from a type of heart attack that affects mainly younger women, called spontaneous coronary artery dissection or SCAD, may benefit most from conservative treatment, letting the body heal on its own.

22 Feb 2018

New data from VOYAGE 2 trial shows promising results for Janssen’s guselkumab treatment

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new data that showed a vast majority of patients with moderate to severe plaque psoriasis receiving TREMFYA (guselkumab), who achieved at least a 90 percent improvement in the Psoriasis Area and Severity Index (PASI 90) at week 28, maintained a PASI 90 response with continuous treatment through week 72.

From J&J Innovative Medicine 22 Feb 2018